Demand for clinical research organizations will increase through 2036, with drug discovery services at 41.7% of service revenue in 2026. In-house production holds 54.2% of production-based revenue in 2026. The market stands at USD 79.6 billion in 2026 and is projected to total USD 178.1 billion by 2036.